Andere talen Administer Oyj

Aandelen

ADMIN

FI4000513411

Vertraagde tijd Nasdaq Helsinki Andere beurzen 16:12:40 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
2,5 ^EUR	0,00%		-3,85%	+3,73%

11/04	Gerresheimer aandelen omlaag over vooruitzichten, maar belangrijke contracten bevestigd	RE
10/04	Administer Plc kondigt benoemingen Auditcomité aan	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

BioXcel Therapeutics to Launch At-Home Trial of Potential Bipolar, Schizophrenia Agitation Treatment	22/04
Gerresheimer shares down on outlook, but key contracts confirmed	11/04
Resolutions of Administer Plc’s Annual General Meeting 2024 and the organising meeting of the Board of Directors	10/04
Administer Plc Announces Audit Committee Appointments	10/04
Administer Plc Announces No Dividend for the Financial Year Ended 31 December 2023	10/04
Administer Plc: Managers' Transactions, Herranen	05/04
Scotland's parliament considers assisted dying as poll shows support	28/03
Stoke Therapeutics Rises After Investigational Drug Shows Improvement in Dravet Syndrome Patients	26/03
Reinsurance Group in C$5.8 Billion Coinsurance Deal With Canada's Manulife	25/03
Administer Plc’s annual report for the year 2023 has been published	20/03
Administer Plc: Managers' Transactions, Herranen	19/03
Notice to Annual General Meeting of Administer Plc	18/03
Administer Oyj Reports Earnings Results for the Full Year Ended December 31, 2023	07/03
Anima sees net outflows, while Fineco, Mediolanum post inflows	06/03
Insider information: Administer Group renews its strategy to ensure profitable growth – new financial targets and dividend policy	06/03
Administer Oyj Provides Earnings Guidance for 2026	06/03
Administer Plc: Growth continued strong, main focus in increasing profitability	06/03
UK chancellor hopes to reduce tax burden in "prudent" budget	03/03
Eagle Plains And Refined Metals Execute Option Agreement For The Dufferin Uranium Project	27/02
Arch Biopartners on Pre-IND Meeting With FDA to Repurpose Cilastatin as New Treatment to Prevent Acute Kidney Injury	27/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Administer Oyj

Aandelen

ADMIN

FI4000513411

Andere talen

Filters